Pyroptosis, inflammasome, and gasdermins in tumor immunity.


Journal

Innate immunity
ISSN: 1753-4267
Titre abrégé: Innate Immun
Pays: United States
ID NLM: 101469670

Informations de publication

Date de publication:
01 2023
Historique:
medline: 8 5 2023
pubmed: 13 1 2023
entrez: 12 1 2023
Statut: ppublish

Résumé

The gasdermins (GSDM), a family of pore-forming proteins, consist of gasdermin A (GSDMA), gasdermin B (GSDMB), gasdermin C (GSDMC), gasdermin D (GSDMD), gasdermin E (GSDME) and DFNB59 (Pejvakin (PJVK)) in humans. These proteins play an important role in pyroptosis. Among them, GSDMD is the most extensively studied protein and is identified as the executioner of pyroptosis. Other family members have also been implicated in certain cancers. As a unique form of programmed cell death, pyroptosis is closely related to tumor progression, and the inflammasome, an innate immune mechanism that induces inflammation and pyroptosis. In this review, we explore the current developments of pyroptosis, the inflammasome, and especially we review the gasdermin family members and their role in inducing pyroptosis and the possible therapeutic values in antitumor effects.

Identifiants

pubmed: 36632024
doi: 10.1177/17534259221143216
pmc: PMC10164276
doi:

Substances chimiques

Inflammasomes 0
Gasdermins 0
Neoplasm Proteins 0
GSDMC protein, human 0
Biomarkers, Tumor 0
Pore Forming Cytotoxic Proteins 0
GSDMA protein, human 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-13

Références

Trends Microbiol. 2001 Mar;9(3):113-4
pubmed: 11303500
Sci Immunol. 2018 Aug 24;3(26):
pubmed: 30143554
Cell Chem Biol. 2017 Apr 20;24(4):507-514.e4
pubmed: 28392147
EMBO J. 2019 May 15;38(10):
pubmed: 30902848
Cell Prolif. 2019 Mar;52(2):e12563
pubmed: 30525268
J Biomed Sci. 2015 Jun 24;22:44
pubmed: 26100518
Immunity. 2019 Jul 16;51(1):43-49.e4
pubmed: 31097341
Nature. 2012 Jan 18;481(7381):278-86
pubmed: 22258606
Cell Death Dis. 2014 Feb 27;5:e1088
pubmed: 24577086
Nature. 2017 Jul 6;547(7661):99-103
pubmed: 28459430
Sci Signal. 2019 May 21;12(582):
pubmed: 31113851
Cell. 2021 Jun 10;184(12):3178-3191.e18
pubmed: 34022140
Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70
pubmed: 1103152
Cancer Sci. 2007 Jan;98(1):88-95
pubmed: 17083569
Cell. 2018 May 3;173(4):920-933.e13
pubmed: 29576451
Biomaterials. 2020 Sep;254:120142
pubmed: 32485591
Nature. 2014 Oct 9;514(7521):187-92
pubmed: 25119034
Immunol Rev. 2015 May;265(1):22-34
pubmed: 25879281
PLoS One. 2017 Feb 27;12(2):e0172707
pubmed: 28241063
Chembiochem. 2015 Dec;16(18):2557-61
pubmed: 26388514
Mol Med Rep. 2020 Jan;21(1):360-370
pubmed: 31939622
Genomics. 2004 Nov;84(5):824-35
pubmed: 15475261
Cell Res. 2021 Sep;31(9):980-997
pubmed: 34012073
J Mol Biol. 2018 Sep 14;430(18 Pt B):3068-3080
pubmed: 29990470
Nature. 2022 Feb;602(7897):496-502
pubmed: 35110732
Lancet Oncol. 2012 Aug;13(8):790-801
pubmed: 22658655
Nat Rev Immunol. 2017 Mar;17(3):151-164
pubmed: 28138137
J Biol Chem. 2001 Jul 27;276(30):28309-13
pubmed: 11390368
Oncol Rep. 2018 Oct;40(4):1971-1984
pubmed: 30106450
Trends Cell Biol. 2017 Sep;27(9):673-684
pubmed: 28619472
Nat Rev Immunol. 2017 Feb;17(2):97-111
pubmed: 27748397
Cell Host Microbe. 2018 Jul 11;24(1):97-108.e4
pubmed: 29937272
Nature. 2016 Jul 06;535(7610):153-8
pubmed: 27383986
Science. 2020 May 29;368(6494):
pubmed: 32299851
J Exp Med. 2016 Sep 19;213(10):2113-28
pubmed: 27573815
J Hematol Oncol. 2020 Aug 10;13(1):110
pubmed: 32778143
Genes Chromosomes Cancer. 2009 Mar;48(3):261-71
pubmed: 19051310
Transl Oncol. 2008 Jul;1(2):73-83
pubmed: 18633457
Int J Oncol. 2004 Sep;25(3):765-70
pubmed: 15289881
Immunity. 2022 Apr 12;55(4):623-638.e5
pubmed: 35385697
Cell Rep. 2018 Mar 13;22(11):2924-2936
pubmed: 29539421
EMBO Rep. 2019 Sep;20(9):e48235
pubmed: 31353801
Trends Immunol. 2017 Apr;38(4):261-271
pubmed: 28196749
Jpn J Cancer Res. 2001 Feb;92(2):140-51
pubmed: 11223543
Oncogene. 2007 Oct 4;26(45):6488-98
pubmed: 17471240
Mamm Genome. 2000 Sep;11(9):718-24
pubmed: 10967128
iScience. 2020 Sep 29;23(10):101612
pubmed: 33089101
Genome Res. 2001 Aug;11(8):1392-403
pubmed: 11483580
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3728-3737
pubmed: 32015113
Cancer Lett. 2019 May 28;450:22-31
pubmed: 30771436
PLoS Pathog. 2019 Jun 28;15(6):e1007886
pubmed: 31251782
Nat Rev Immunol. 2016 Jan;16(1):7-21
pubmed: 26655628
Nat Rev Cancer. 2004 Jun;4(6):437-47
pubmed: 15170446
Int Immunopharmacol. 2019 Sep;74:105713
pubmed: 31276977
J Exp Med. 2019 Nov 4;216(11):2453-2465
pubmed: 31548300
BMC Cancer. 2020 Jan 10;20(1):28
pubmed: 31924176
Cell Death Differ. 2016 May;23(5):748-56
pubmed: 26915291
Immunity. 2004 Mar;20(3):319-25
pubmed: 15030775
Nature. 1992 Jul 9;358(6382):167-9
pubmed: 1614548
Int Immunopharmacol. 2020 Jul;84:106489
pubmed: 32304992
J Hum Genet. 2006;51(8):652-664
pubmed: 16897187
Eur J Immunol. 2015 Oct;45(10):2918-26
pubmed: 26173988
Trends Cell Biol. 2021 Nov;31(11):924-939
pubmed: 34284921
Sci Rep. 2018 Jan 31;8(1):1952
pubmed: 29386662
Nature. 2015 Oct 29;526(7575):666-71
pubmed: 26375259
Lancet Infect Dis. 2008 Jan;8(1):32-43
pubmed: 18063412
Clin Transl Med. 2021 Jan;11(1):e269
pubmed: 33463071
Sci Immunol. 2021 Oct 22;6(64):eabj3859
pubmed: 34678046
Cell Death Dis. 2020 Jun 18;11(6):470
pubmed: 32555186
Sci Immunol. 2020 Jan 17;5(43):
pubmed: 31953257
Mol Cell. 2002 Aug;10(2):417-26
pubmed: 12191486
Genomics. 2007 May;89(5):618-29
pubmed: 17350798
Clin Cancer Res. 2019 Aug 1;25(15):4846-4858
pubmed: 31064780
PLoS One. 2016 Nov 11;11(11):e0166422
pubmed: 27835699
Hum Mol Genet. 2014 Feb 1;23(3):717-29
pubmed: 24070868
Nature. 2022 May;605(7910):527-531
pubmed: 35545676
J Biol Chem. 2018 May 4;293(18):7058-7067
pubmed: 29414788
Nature. 2011 Oct 16;479(7371):117-21
pubmed: 22002608
Nature. 2015 Oct 29;526(7575):660-5
pubmed: 26375003
Pathology. 2008 Jan;40(1):13-24
pubmed: 18038310
Cold Spring Harb Perspect Biol. 2020 Mar 2;12(3):
pubmed: 31451512
Cell Res. 2014 Nov;24(11):1286-7
pubmed: 25091449
Nature. 2020 Mar;579(7799):415-420
pubmed: 32188940
EMBO J. 2016 Aug 15;35(16):1766-78
pubmed: 27418190
Nature. 2016 Jul 7;535(7610):111-6
pubmed: 27281216
Nat Genet. 2006 Jul;38(7):770-8
pubmed: 16804542
Nat Commun. 2017 Jan 03;8:14128
pubmed: 28045099
Nature. 2018 May;557(7703):62-67
pubmed: 29695864
Science. 2018 Mar 23;359(6382):1350-1355
pubmed: 29567705
Immunity. 2018 Sep 18;49(3):413-426.e5
pubmed: 30170814
Nat Cell Biol. 2020 Oct;22(10):1264-1275
pubmed: 32929201
Nature. 2020 Mar;579(7799):421-426
pubmed: 32188939
Nat Cell Biol. 2013 Oct;15(10):1197-1205
pubmed: 24036476
Sci Transl Med. 2016 Mar 2;8(328):328rv4
pubmed: 26936508
Nat Rev Cancer. 2008 Aug;8(8):618-31
pubmed: 18633355
Nat Genet. 1998 Oct;20(2):194-7
pubmed: 9771715
Nat Commun. 2019 Apr 11;10(1):1689
pubmed: 30976076
Nat Rev Immunol. 2017 Mar;17(3):208-214
pubmed: 28163301
Nat Rev Immunol. 2016 Jul;16(7):407-20
pubmed: 27291964
Cell Rep. 2019 Jun 18;27(12):3646-3656.e5
pubmed: 31216481
Nat Immunol. 2009 Mar;10(3):266-72
pubmed: 19158679

Auteurs

Xiaohu Ouyang (X)

Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Junfen Zhou (J)

Department of Nuclear Medicine, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Lan Lin (L)

Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zili Zhang (Z)

Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Shanshan Luo (S)

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Desheng Hu (D)

Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Key Laboratory of Biological Targeted Therapy, the Ministry of Education, Wuhan, China.
Clinical Research Center of Cancer Immunotherapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH